When Vitamin D Sends You to the Hospital: Real Published Cases of Hypervitaminosis D — and What They Should Teach Us

Yoon Hang Kim, MD, MPH    •    www.directintegrativecare.com

Vitamin D is one of the most studied, most prescribed, and most self-administered nutrients of the last two decades, and for good reason. Adequate vitamin D status supports bone integrity, immune regulation, cardiovascular function, insulin sensitivity, and numerous processes that touch nearly every organ system. At Direct Integrative Care, we routinely measure and optimize vitamin D as part of comprehensive care. Yet the same popularity that has transformed vitamin D into a household supplement has produced a steady and well-documented rise in hospitalizations for hypervitaminosis D — vitamin D toxicity.

This is not a theoretical risk. It is a clinical problem reported in peer-reviewed journals across pediatric, adult, and geriatric populations, and the underlying pattern is almost always the same: high doses, no laboratory monitoring, and often the encouragement of a non-physician advisor who underestimates the calcium, renal, and bone consequences of chronic supraphysiologic vitamin D exposure. The cases that follow are real, published, and cautionary.

The Scale of the Problem

Between 2000 and 2014, United States poison control centers recorded more than twenty-five thousand cases of vitamin D toxicity, with a roughly sixteen-hundred percent increase in reported exposures between 2005 and 2011 alone. More recent data from America’s Poison Centers captured nearly twelve thousand vitamin D exposure cases in a single reporting year — more than the total number of exposures for vitamins A, B, C, and E combined. While most of these exposures did not result in severe illness, the overall trajectory mirrors the cultural enthusiasm for ever-higher dosing. The authoritative StatPearls clinical reference notes that severe hypercalcemia from vitamin D toxicity can progress to acute renal failure requiring hemodialysis, and that permanent kidney injury, though uncommon, is a documented complication.

Case One: A Middle-Aged Man on 150,000 IU per Day

In July 2022, Alkundi and colleagues from East Kent Hospitals University NHS Foundation Trust published a case report in BMJ Case Reports describing a middle-aged man who had been taking more than twenty over-the-counter supplements on the advice of a nutritional therapist he had found through a radio program. Among those supplements was vitamin D at 50,000 international units three times daily — a total of 150,000 IU per day, roughly 375 times the common adult recommended intake. Over three months he developed recurrent vomiting, nausea, abdominal pain, leg cramps, tinnitus, dry mouth, excessive thirst, diarrhea, and nearly twenty-eight pounds of unintentional weight loss. By the time he arrived at hospital, he had acute kidney injury, a markedly elevated twenty-five hydroxyvitamin D, and significant hypercalcemia. He required an eight-day admission for intravenous calcium-lowering therapy. On follow-up two months later his calcium had nearly normalized, but his vitamin D level remained elevated and required ongoing surveillance — a reflection of how long cholecalciferol lingers in adipose tissue once stored.

Case Two: Nineteen Adults Hospitalized With Acute Kidney Injury

A single-institution case series by Chowdry, summarized in the 2018 Nutrients review by Galior and colleagues, described nineteen patients aged forty-five to eighty-nine who developed vitamin D toxicity-induced acute kidney injury after physician-prescribed vitamin D for common complaints such as bone pain, generalized aches, fatigue, and myalgia. On admission their median serum calcium was 13.0 mg/dL, and their median serum twenty-five hydroxyvitamin D was 371 ng/mL, with some values reaching 988 ng/mL. Sixteen of the nineteen had acute kidney injury, three had superimposed acute-on-chronic kidney injury, eleven had nausea and vomiting, nine had constipation, seven had altered mental status, and two developed acute pancreatitis. Several lost clinically significant weight. The sobering lesson here is that these were not patients taking megadoses from a wellness influencer. They were patients whose prescribing clinicians did not perform the follow-up monitoring that would have caught the problem before it became an admission.

Case Three: Compounding Errors and Unsuspecting Patients

Not every case of vitamin D toxicity involves intentional megadosing. A 2014 case report by Marins and colleagues in Einstein (São Paulo) described a fifty-three-year-old man with diabetes, hypertension, and non-dialysis chronic kidney disease who had been prescribed 2,000 IU of vitamin D daily. When he presented with worsening renal function, pruritus, muscle weakness, anorexia, and weight loss, his serum twenty-five hydroxyvitamin D exceeded 1,000 ng/mL. Laboratory analysis of the compounded capsules he had been taking revealed they contained two thousand times the expected dose of vitamin D per capsule. In a parallel lesson from pediatrics, Anik and colleagues and Kara and colleagues reported ten young children hospitalized with bilateral nephrocalcinosis and total serum calcium values up to 19.4 mg/dL after receiving what was supposed to be a modest 200 IU daily appetite supplement; the actual vitamin D content of the product was four thousand times the labeled concentration. These reports underscore why third-party testing and sourcing from reputable manufacturers is not a luxury — it is a safety measure.

Case Four: The Elderly and the Caregiver Trap

Older adults have less renal reserve and narrower metabolic tolerances, and they are at particular risk when a well-meaning caregiver administers supplements without physician input. In late 2024, Yu and colleagues published a case in Medicine describing an elderly woman brought to the emergency department with three days of progressive lower-limb weakness, delirium, and abdominal distension. Her initial laboratory studies revealed hyponatremia, hypokalemia, hypomagnesemia, and severe hypercalcemia. Only on careful questioning did the family reveal that she had been receiving excessive liquid vitamin D3 over the preceding three weeks, administered by her spouse under the belief that more was better. A separate 2017 case presented at the European Congress of Endocrinology described a seventy-nine-year-old woman admitted with acute pancreatitis and a serum calcium of 13.8 mg/dL after she self-administered twelve ampules of vitamin D3 in a single month; her twenty-five hydroxyvitamin D exceeded 450 ng/mL. In both cases, the patients were at real risk of permanent renal and cardiovascular sequelae before the etiology was even recognized.

Case Five: Pediatric Harm From “Harmless” Supplements

Pediatric cases are among the most sobering because infants and toddlers cannot advocate for themselves. Pizzini and colleagues reported in 2024 on a twenty-two-month-old girl admitted with early nephrocalcinosis following an unsupervised vitamin D food supplement. Gerard and colleagues described in Frontiers in Pediatrics an infant whose parents inadvertently administered forty to fifty thousand IU daily — fifty times the upper tolerable limit — due to a confusing switch between two non-equivalent pediatric formulations. The child required a fifteen-day hospitalization for severe hypercalcemia and faced the possibility of long-term nephrocalcinosis and stone disease. In 2025, Kasiri and colleagues reported a previously healthy three-year-old who accidentally ingested 800,000 IU of cholecalciferol in a single event. Although this particular child remained clinically asymptomatic, he required eleven days of inpatient management, his serum twenty-five hydroxyvitamin D peaked at 880 ng/mL on day five, and his vitamin D levels did not normalize for three months — a vivid reminder of the extraordinarily long half-life of the parent compound stored in adipose tissue.

Why This Happens: The Pharmacology in Brief

Vitamin D is a fat-soluble prohormone that is stored in adipose tissue and liver and slowly released into circulation. The circulating form, twenty-five hydroxyvitamin D, has a half-life of roughly fifteen days; the parent compound cholecalciferol persists considerably longer. When serum twenty-five hydroxyvitamin D is driven into supraphysiologic ranges — generally above 150 ng/mL — vitamin D upregulates intestinal calcium absorption and mobilizes calcium from bone. The consequence is hypercalcemia. Hypercalcemia in turn impairs renal concentrating ability and causes polyuria and dehydration, which further amplifies serum calcium in a dangerous positive feedback loop. Downstream complications include acute kidney injury, nephrocalcinosis, nephrolithiasis, pancreatitis, QT shortening with arrhythmia risk, and a spectrum of neurologic symptoms ranging from confusion to frank delirium. A subset of patients never fully recover baseline renal function.

Because the storage and release dynamics are measured in weeks to months rather than hours, symptoms often persist long after the offending supplement is discontinued, which explains why simply stopping the pills is rarely sufficient treatment in severe cases. Hospital management frequently requires aggressive hydration, loop diuretics, corticosteroids, calcitonin, bisphosphonates or denosumab, and in refractory cases hemodialysis.

Warning Signs Patients and Families Should Recognize

The symptoms of vitamin D toxicity are unfortunately non-specific, which is precisely why they are so often ignored for weeks before anyone connects them to the bottle on the nightstand. Common presenting complaints include persistent nausea, vomiting, abdominal pain, constipation, loss of appetite, unexplained weight loss, excessive thirst, frequent urination, dry mouth, muscle weakness, bone pain, generalized fatigue, confusion, mood changes, and in severe cases delirium. Anyone taking high-dose vitamin D who develops these symptoms should stop the supplement immediately and contact their physician for laboratory evaluation — a simple measurement of serum calcium, twenty-five hydroxyvitamin D, and creatinine can rapidly determine whether hypervitaminosis D is the cause.

Principles of Safe Vitamin D Use

Vitamin D remains a profoundly valuable therapy when used thoughtfully. The issue is not the molecule; the issue is unsupervised, uncalibrated, and unmonitored dosing. The framework we use at Direct Integrative Care reduces to a few principles. First, establish a baseline: every patient taking more than routine maintenance doses should have a baseline serum twenty-five hydroxyvitamin D, total and ionized calcium, albumin, phosphorus, intact parathyroid hormone, and a measure of kidney function. Second, individualize the dose based on body weight, baseline status, absorption, age, and coexisting conditions. A 5,000 IU daily dose that is appropriate for one patient may be inadequate for another and dangerous for a third. Third, monitor: patients on daily doses above 5,000 IU should have periodic laboratory assessment, and those on substantially higher doses require more frequent monitoring together with a clear clinical rationale. Fourth, respect known contraindications and cautions, which include primary hyperparathyroidism, granulomatous diseases such as sarcoidosis and tuberculosis, active nephrolithiasis, certain lymphomas, advanced chronic kidney disease, and concurrent thiazide diuretic therapy. Fifth, be cautious with anyone — credentialed or not — who recommends megadose protocols without the laboratory infrastructure to monitor them.

Physician-supervised high-dose vitamin D protocols do exist for selected autoimmune indications and are the subject of ongoing investigation. These are emphatically not self-directed regimens. They require baseline and ongoing laboratory surveillance, strict dietary calcium restriction, adequate daily hydration, exercise to counter accelerated bone turnover, and a clinician trained in the protocol who can interpret results and adjust the dose in real time. The difference between therapeutic and toxic vitamin D is rarely the molecule itself; it is supervision.

The Bottom Line

The published cases reviewed here share a common pattern: good intentions, high doses, and no monitoring. Vitamin D has real benefits when used correctly and real dangers when it is not. If you are taking more than 5,000 IU per day without periodic laboratory monitoring, or if you have recently started an aggressive supplement regimen at the recommendation of someone who cannot order your labs or manage your calcium, please speak with your physician. A five-dollar blood test today is far less expensive — financially, physically, and in quality of life — than a week in the hospital with acute kidney injury later.

References

1. Alkundi A, Momoh R, Musa A, Nwafor N. Vitamin D intoxication and severe hypercalcaemia complicating nutritional supplements misuse. BMJ Case Reports. 2022;15(7):e250553. doi:10.1136/bcr-2022-250553.

2. Galior K, Grebe S, Singh R. Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Nutrients. 2018;10(8):953. doi:10.3390/nu10080953.

3. Asif A, Farooq N. Vitamin D Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 May 24. PMID: 32491799. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557876/.

4. Marins TA, Galvão TFG, Korkes F, et al. Vitamin D intoxication: case report. Einstein (São Paulo). 2014;12(2):242–244. doi:10.1590/S1679-45082014RC2860.

5. Yu CH, Tseng HK, Chien DK, Liao EC. Over-supplement of vitamin D may cause delirium, abdominal distension, and muscle weakness in the elderly: A case report and literature review. Medicine (Baltimore). 2024;103(52):e41057. doi:10.1097/MD.0000000000041057.

6. Kasiri H, et al. A 3-Year-Old Child With Incidental High-Dose Vitamin D Intoxication: A Case Report and Literature Review. Case Reports in Endocrinology. 2025;2025:6614996. doi:10.1155/crie/6614996.

7. Pizzini C, Ossato A, Realdon N, Tessari R. Case Report: Nephrocalcinosis in an infant due to vitamin-D food supplement overdose. Front Pediatr. 2024;12:1485814. doi:10.3389/fped.2024.1485814.

8. Gerard AO, Fresse A, Gast M, et al. Case Report: Severe Hypercalcemia Following Vitamin D Intoxication in an Infant, the Underestimated Danger of Dietary Supplements. Front Pediatr. 2022;10:816965. doi:10.3389/fped.2022.816965.

9. Ipek IO, et al. Vitamin D intoxication caused hypercalcemia: Case report. Endocrine Abstracts. 2017;49:EP249. 19th European Congress of Endocrinology.

10. America’s Poison Centers. National Poison Data System — Annual Report (most recent). Available at: https://poisoncenters.org/.